Oxford Instruments (OXINF) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning everyone and welcome to Oxford Instruments' full year results presentation. Before I get into the presentation, just a quick comment on the unscheduled delay to results. The delay was due to a technical accounting matter which was raised to us in the very early hours of Tuesday morning. Our auditors have since resolved this internally. There has been no changes in our financial statements or to the disclosures since Monday. So with that, good to see you guys in the room and thanks to those of you joining us online. So I'm joined today for the first time by Paul Fry, who's been with us since January getting to know Oxford Instruments, our teams and our new strategy. Paul took up the role of CFO at the start of April. So welcome, Paul. It's been great to get started together and I'm really looking forward to working with you to realise the full potential of Oxford Instruments. It's been a really good year for Oxford Instruments with strong revenue and profit growth, margin improvement in both parts of the business and a really good progress towards our medium term targets. And I'm delighted that on Tuesday we were able to announce the sale of our quantum focused nanoscience business for 60 million pounds having turned around its performance during the year. Greater focus, good for margins and bolstering an already strong balance sheet leading to the announcement of the share buyback on Tuesday. So this is what I mean by a really good year. 6.5% revenue growth, particularly strong in the second half as we signalled at half year. Double digit profit growth and importantly a significant uplift in group margin to 17.8% all at constant currency. Performance in our markets continued the momentum from the first half into H2. Strong double digit growth in semicond...